Approval · Notice of Compliance 28449 · 2022
PHEBURANE: Notice of Compliance 28449
Issued June 23, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28449
- Date
- June 23, 2022
- Company
- Medunik CanadaBlainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To revise the Inner and Outer labels due to change in printing company for artworks.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHEBURANE | Not yet assigned | — |
Medicinal ingredients
- SODIUM PHENYLBUTYRATE 483 MG per G